136 related articles for article (PubMed ID: 33405241)
1. Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma.
Lin YT; Wang HC; Tsai MH; Su YY; Yang MY; Chien CY
Cancer; 2021 May; 127(10):1606-1619. PubMed ID: 33405241
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
3. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
Xie M; Yi X; Wang R; Wang L; He G; Zhu M; Qi C; Liu Y; Ye Y; Tan S; Tang A
Cell Physiol Biochem; 2014; 33(5):1475-83. PubMed ID: 24854624
[TBL] [Abstract][Full Text] [Related]
4. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
Zhang J; Zhou J; Xiao S
Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway.
Lin YT; Wang HC; Hsu YC; Cho CL; Yang MY; Chien CY
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644386
[TBL] [Abstract][Full Text] [Related]
7. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
8. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
[TBL] [Abstract][Full Text] [Related]
9. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
[TBL] [Abstract][Full Text] [Related]
10. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
[TBL] [Abstract][Full Text] [Related]
12. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
Zhang M; Zhou X; Zhou K
Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
[TBL] [Abstract][Full Text] [Related]
14. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
[TBL] [Abstract][Full Text] [Related]
16. Luteolin-7-O-glucoside inhibits cell proliferation and modulates apoptosis through the AKT signaling pathway in human nasopharyngeal carcinoma.
Ho HY; Chen PJ; Lo YS; Lin CC; Chuang YC; Hsieh MJ; Chen MK
Environ Toxicol; 2021 Oct; 36(10):2013-2024. PubMed ID: 34165247
[TBL] [Abstract][Full Text] [Related]
17. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
[TBL] [Abstract][Full Text] [Related]
18. Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma.
Zhang Q; Gao Y; Zhang Y; Jing M; Wang D; Wang Y; Khattak S; Qi H; Cai C; Zhang J; Ngowi EE; Khan NH; Li T; Ji A; Jiang Q; Ji X; Li Y; Wu D
Oncogene; 2022 Dec; 41(49):5238-5252. PubMed ID: 36310322
[TBL] [Abstract][Full Text] [Related]
19. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.
Yang F; Qian XJ; Qin W; Deng R; Wu XQ; Qin J; Feng GK; Zhu XF
PLoS One; 2013; 8(3):e59879. PubMed ID: 23533654
[TBL] [Abstract][Full Text] [Related]
20. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
Li W; Ma H; Liu M
Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
